Ramucirumab for recurrent/refractory synovial sarcoma
This study involves taking a study drug called
ramucirumab. The overall goal of this study is to see how effective ramucirumab
is when given in combination with gemcitabine and docetaxel in children
and young adults with synovial sarcoma.